Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Negative-Pressure Wound Therapy | 27 | 2023 | 154 | 8.770 |
Why?
|
Wound Healing | 102 | 2024 | 2781 | 8.260 |
Why?
|
Tissue Expansion | 17 | 2020 | 160 | 5.720 |
Why?
|
Adipose Tissue | 24 | 2023 | 3298 | 4.270 |
Why?
|
Diabetic Foot | 22 | 2024 | 380 | 4.060 |
Why?
|
Skin, Artificial | 18 | 2023 | 89 | 3.880 |
Why?
|
Wounds and Injuries | 28 | 2021 | 2475 | 3.350 |
Why?
|
Neovascularization, Physiologic | 28 | 2022 | 1332 | 3.300 |
Why?
|
Surgical Flaps | 41 | 2024 | 1669 | 3.220 |
Why?
|
Skin Transplantation | 33 | 2022 | 1083 | 3.190 |
Why?
|
Hidradenitis Suppurativa | 8 | 2022 | 173 | 3.150 |
Why?
|
Surgery, Plastic | 16 | 2019 | 643 | 2.980 |
Why?
|
Mammaplasty | 20 | 2023 | 1241 | 2.890 |
Why?
|
Skin | 40 | 2023 | 4464 | 2.560 |
Why?
|
Burns | 29 | 2024 | 1849 | 2.560 |
Why?
|
Tissue Scaffolds | 12 | 2021 | 925 | 2.320 |
Why?
|
Adipogenesis | 6 | 2022 | 358 | 2.270 |
Why?
|
Glycosaminoglycans | 17 | 2021 | 605 | 2.270 |
Why?
|
Adipocytes | 7 | 2021 | 1178 | 2.050 |
Why?
|
Surgical Wound Infection | 13 | 2022 | 1521 | 2.010 |
Why?
|
Tissue Engineering | 12 | 2021 | 1868 | 1.910 |
Why?
|
Dermis | 9 | 2022 | 202 | 1.910 |
Why?
|
Collagen | 28 | 2022 | 2634 | 1.860 |
Why?
|
Sternotomy | 4 | 2021 | 128 | 1.560 |
Why?
|
Diabetes Mellitus, Experimental | 17 | 2023 | 1110 | 1.540 |
Why?
|
Tissue Expansion Devices | 5 | 2019 | 156 | 1.500 |
Why?
|
Wound Closure Techniques | 4 | 2021 | 87 | 1.500 |
Why?
|
Diabetes Mellitus | 19 | 2024 | 5815 | 1.430 |
Why?
|
Free Tissue Flaps | 6 | 2024 | 327 | 1.430 |
Why?
|
Subcutaneous Fat | 5 | 2019 | 393 | 1.420 |
Why?
|
Diabetes Complications | 7 | 2013 | 1317 | 1.410 |
Why?
|
Regeneration | 14 | 2019 | 1505 | 1.410 |
Why?
|
Epidermis | 9 | 2014 | 528 | 1.390 |
Why?
|
Bandages | 10 | 2021 | 269 | 1.380 |
Why?
|
Postoperative Care | 5 | 2021 | 1468 | 1.300 |
Why?
|
Publishing | 9 | 2021 | 832 | 1.260 |
Why?
|
Acetylglucosamine | 4 | 2011 | 189 | 1.260 |
Why?
|
Guidelines as Topic | 7 | 2018 | 1384 | 1.200 |
Why?
|
Granulation Tissue | 13 | 2013 | 92 | 1.190 |
Why?
|
Keratinocytes | 7 | 2021 | 790 | 1.150 |
Why?
|
Cosmetic Techniques | 3 | 2021 | 149 | 1.130 |
Why?
|
Lymphedema | 4 | 2023 | 526 | 1.130 |
Why?
|
Surgical Mesh | 4 | 2018 | 310 | 1.100 |
Why?
|
Keloid | 2 | 2019 | 54 | 1.010 |
Why?
|
Surgical Procedures, Operative | 7 | 2018 | 1903 | 1.010 |
Why?
|
Absorbable Implants | 3 | 2019 | 338 | 0.970 |
Why?
|
Postoperative Complications | 30 | 2024 | 15532 | 0.970 |
Why?
|
Cell Proliferation | 29 | 2020 | 10405 | 0.970 |
Why?
|
Skin Ulcer | 4 | 2016 | 129 | 0.960 |
Why?
|
Stress, Mechanical | 7 | 2019 | 1664 | 0.960 |
Why?
|
Varicose Ulcer | 3 | 2022 | 55 | 0.930 |
Why?
|
Skin Physiological Phenomena | 7 | 2014 | 188 | 0.930 |
Why?
|
Ketorolac | 2 | 2015 | 94 | 0.910 |
Why?
|
Omentum | 3 | 2013 | 168 | 0.860 |
Why?
|
Sternum | 4 | 2021 | 175 | 0.850 |
Why?
|
Debridement | 8 | 2021 | 492 | 0.840 |
Why?
|
Subcutaneous Tissue | 2 | 2013 | 132 | 0.810 |
Why?
|
General Surgery | 8 | 2019 | 1674 | 0.800 |
Why?
|
Adiposity | 2 | 2024 | 1856 | 0.800 |
Why?
|
Pressure Ulcer | 3 | 2020 | 156 | 0.800 |
Why?
|
Tissue and Organ Harvesting | 3 | 2014 | 372 | 0.790 |
Why?
|
Humans | 249 | 2024 | 757566 | 0.790 |
Why?
|
Polyurethanes | 5 | 2022 | 108 | 0.780 |
Why?
|
Adipokines | 1 | 2024 | 310 | 0.770 |
Why?
|
Animals | 106 | 2023 | 167718 | 0.770 |
Why?
|
Mice | 66 | 2023 | 81066 | 0.750 |
Why?
|
Lipectomy | 1 | 2022 | 113 | 0.740 |
Why?
|
Seroma | 3 | 2022 | 76 | 0.740 |
Why?
|
Suction | 8 | 2022 | 263 | 0.730 |
Why?
|
Endothelial Cells | 10 | 2021 | 3526 | 0.730 |
Why?
|
Postoperative Hemorrhage | 2 | 2015 | 412 | 0.730 |
Why?
|
Cicatrix | 9 | 2022 | 780 | 0.720 |
Why?
|
Graft Survival | 11 | 2021 | 3794 | 0.720 |
Why?
|
Occlusive Dressings | 8 | 2014 | 52 | 0.710 |
Why?
|
Blood Platelets | 6 | 2008 | 2476 | 0.710 |
Why?
|
Penile Diseases | 1 | 2020 | 45 | 0.700 |
Why?
|
Breast Implants | 4 | 2022 | 410 | 0.690 |
Why?
|
Scrotum | 1 | 2020 | 116 | 0.680 |
Why?
|
Transplantation, Autologous | 11 | 2021 | 2113 | 0.680 |
Why?
|
Chemokine CXCL12 | 3 | 2018 | 454 | 0.680 |
Why?
|
Research Design | 7 | 2017 | 6152 | 0.670 |
Why?
|
Platelet-Rich Plasma | 3 | 2021 | 178 | 0.660 |
Why?
|
Prone Position | 1 | 2020 | 196 | 0.660 |
Why?
|
Mesenchymal Stem Cells | 6 | 2022 | 1631 | 0.660 |
Why?
|
Cicatrix, Hypertrophic | 2 | 2019 | 81 | 0.650 |
Why?
|
Hernia, Ventral | 3 | 2015 | 215 | 0.650 |
Why?
|
Mechanotransduction, Cellular | 3 | 2021 | 530 | 0.640 |
Why?
|
Extracellular Matrix | 7 | 2018 | 1722 | 0.610 |
Why?
|
Equipment and Supplies | 1 | 2020 | 273 | 0.600 |
Why?
|
Fibroblasts | 7 | 2021 | 4087 | 0.590 |
Why?
|
Medical Tourism | 1 | 2018 | 52 | 0.580 |
Why?
|
Ephedrine | 1 | 2017 | 52 | 0.580 |
Why?
|
Technology | 1 | 2020 | 292 | 0.580 |
Why?
|
Surgical Wound Dehiscence | 1 | 2019 | 213 | 0.580 |
Why?
|
Fractures, Open | 2 | 2010 | 105 | 0.580 |
Why?
|
Radiation Injuries | 2 | 2023 | 1184 | 0.570 |
Why?
|
Facial Injuries | 8 | 2022 | 190 | 0.570 |
Why?
|
Mice, Inbred C57BL | 30 | 2022 | 21990 | 0.570 |
Why?
|
Mice, Inbred Strains | 9 | 2018 | 1758 | 0.550 |
Why?
|
Abdominal Wall | 1 | 2018 | 166 | 0.550 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2024 | 10135 | 0.550 |
Why?
|
Delphi Technique | 12 | 2019 | 828 | 0.540 |
Why?
|
Tryptases | 2 | 2014 | 176 | 0.540 |
Why?
|
Biological Products | 2 | 2023 | 903 | 0.540 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2017 | 146 | 0.540 |
Why?
|
Male | 127 | 2024 | 358180 | 0.530 |
Why?
|
Facial Nerve Injuries | 1 | 2016 | 64 | 0.510 |
Why?
|
Freeze Drying | 4 | 2008 | 101 | 0.510 |
Why?
|
Transplantation, Homologous | 7 | 2019 | 4808 | 0.510 |
Why?
|
Evidence-Based Medicine | 8 | 2021 | 3670 | 0.510 |
Why?
|
Vacuum | 5 | 2011 | 65 | 0.510 |
Why?
|
Angiogenesis Inducing Agents | 2 | 2008 | 278 | 0.510 |
Why?
|
Clinical Protocols | 4 | 2017 | 1436 | 0.500 |
Why?
|
Pressure | 2 | 2017 | 1154 | 0.490 |
Why?
|
Publications | 1 | 2017 | 194 | 0.480 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 557 | 0.480 |
Why?
|
Chymases | 1 | 2014 | 73 | 0.480 |
Why?
|
Implant Capsular Contracture | 1 | 2014 | 23 | 0.470 |
Why?
|
Perfusion | 2 | 2018 | 1374 | 0.470 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 2267 | 0.470 |
Why?
|
Silicone Elastomers | 3 | 2014 | 78 | 0.470 |
Why?
|
Female | 123 | 2024 | 389943 | 0.470 |
Why?
|
Platelet Transfusion | 3 | 2007 | 294 | 0.460 |
Why?
|
Lower Extremity | 4 | 2024 | 1188 | 0.460 |
Why?
|
Stromal Cells | 2 | 2018 | 1326 | 0.460 |
Why?
|
Pain, Postoperative | 2 | 2015 | 1715 | 0.460 |
Why?
|
Hydrostatic Pressure | 2 | 2014 | 95 | 0.450 |
Why?
|
Clinical Competence | 9 | 2016 | 4760 | 0.450 |
Why?
|
Random Allocation | 7 | 2019 | 2388 | 0.450 |
Why?
|
Review Literature as Topic | 1 | 2016 | 346 | 0.450 |
Why?
|
Tensile Strength | 3 | 2011 | 330 | 0.450 |
Why?
|
Vasoconstrictor Agents | 1 | 2017 | 651 | 0.440 |
Why?
|
Intraoperative Care | 2 | 2017 | 764 | 0.440 |
Why?
|
Neovascularization, Pathologic | 8 | 2022 | 2638 | 0.440 |
Why?
|
Disease Models, Animal | 18 | 2020 | 18114 | 0.430 |
Why?
|
Wounds, Penetrating | 2 | 2012 | 307 | 0.430 |
Why?
|
Mastectomy | 8 | 2024 | 1834 | 0.420 |
Why?
|
Vascular Endothelial Growth Factor A | 11 | 2022 | 3480 | 0.410 |
Why?
|
Soft Tissue Injuries | 6 | 2022 | 171 | 0.410 |
Why?
|
Facial Paralysis | 3 | 2023 | 345 | 0.410 |
Why?
|
Leg Ulcer | 3 | 2022 | 71 | 0.400 |
Why?
|
Lymph | 1 | 2012 | 77 | 0.400 |
Why?
|
Medical Records | 5 | 2017 | 1406 | 0.400 |
Why?
|
Monitoring, Physiologic | 2 | 2014 | 1780 | 0.400 |
Why?
|
Mast Cells | 4 | 2016 | 1389 | 0.390 |
Why?
|
Personal Satisfaction | 1 | 2016 | 641 | 0.390 |
Why?
|
Ultrasonography, Doppler | 1 | 2014 | 461 | 0.390 |
Why?
|
Burns, Electric | 3 | 2015 | 39 | 0.390 |
Why?
|
Cardiac Surgical Procedures | 2 | 2021 | 3603 | 0.380 |
Why?
|
High-Energy Shock Waves | 1 | 2011 | 33 | 0.380 |
Why?
|
Immunohistochemistry | 14 | 2014 | 11063 | 0.370 |
Why?
|
Transforming Growth Factor alpha | 1 | 2011 | 135 | 0.370 |
Why?
|
Neuropeptides | 3 | 2013 | 943 | 0.370 |
Why?
|
Meta-Analysis as Topic | 1 | 2016 | 1373 | 0.370 |
Why?
|
Breast Neoplasms | 12 | 2024 | 20992 | 0.360 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2011 | 72 | 0.360 |
Why?
|
Microsurgery | 5 | 2009 | 793 | 0.360 |
Why?
|
Nerve Regeneration | 1 | 2016 | 791 | 0.350 |
Why?
|
Intraoperative Complications | 1 | 2017 | 1165 | 0.350 |
Why?
|
Cartilage | 3 | 2014 | 806 | 0.350 |
Why?
|
Registries | 2 | 2017 | 8164 | 0.350 |
Why?
|
Collagen Type I | 3 | 2011 | 616 | 0.350 |
Why?
|
Osteosarcoma | 1 | 2016 | 896 | 0.350 |
Why?
|
Guideline Adherence | 1 | 2020 | 2212 | 0.350 |
Why?
|
Retrospective Studies | 41 | 2024 | 79984 | 0.350 |
Why?
|
Trehalose | 2 | 2007 | 88 | 0.340 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 820 | 0.340 |
Why?
|
Quality Improvement | 7 | 2023 | 3793 | 0.330 |
Why?
|
Stem Cells | 4 | 2014 | 3521 | 0.330 |
Why?
|
Hematoma | 2 | 2019 | 768 | 0.330 |
Why?
|
Serine Endopeptidases | 1 | 2014 | 1020 | 0.330 |
Why?
|
Hematopoietic Stem Cells | 3 | 2018 | 3383 | 0.320 |
Why?
|
Treatment Outcome | 35 | 2024 | 64242 | 0.320 |
Why?
|
Mouth Mucosa | 2 | 2002 | 426 | 0.320 |
Why?
|
Leg | 4 | 2009 | 1088 | 0.320 |
Why?
|
Middle Aged | 68 | 2024 | 219192 | 0.320 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2011 | 284 | 0.320 |
Why?
|
Practice Guidelines as Topic | 8 | 2019 | 7366 | 0.310 |
Why?
|
Antigens, CD1 | 2 | 2021 | 439 | 0.310 |
Why?
|
Fibula | 3 | 2010 | 265 | 0.310 |
Why?
|
Research Report | 2 | 2019 | 367 | 0.300 |
Why?
|
Prosthesis Design | 2 | 2014 | 2105 | 0.300 |
Why?
|
Physical Examination | 1 | 2014 | 1245 | 0.300 |
Why?
|
Actins | 3 | 2012 | 2048 | 0.290 |
Why?
|
Cell Cycle | 1 | 2016 | 2929 | 0.290 |
Why?
|
Adult | 66 | 2024 | 219725 | 0.290 |
Why?
|
Platelet-Derived Growth Factor | 3 | 2007 | 617 | 0.290 |
Why?
|
Tibial Fractures | 2 | 2010 | 264 | 0.290 |
Why?
|
Bronchial Fistula | 2 | 2023 | 83 | 0.280 |
Why?
|
Prostheses and Implants | 1 | 2014 | 1269 | 0.280 |
Why?
|
Thigh | 2 | 2008 | 241 | 0.280 |
Why?
|
Biocompatible Materials | 4 | 2019 | 1686 | 0.270 |
Why?
|
Accidents, Occupational | 2 | 1999 | 249 | 0.270 |
Why?
|
Nerve Fibers | 1 | 2010 | 708 | 0.270 |
Why?
|
Pleural Diseases | 2 | 2023 | 137 | 0.270 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 4565 | 0.270 |
Why?
|
Obesity | 5 | 2024 | 12870 | 0.270 |
Why?
|
Hot Temperature | 3 | 2005 | 1434 | 0.270 |
Why?
|
Femoral Artery | 3 | 2008 | 824 | 0.270 |
Why?
|
MicroRNAs | 5 | 2021 | 3780 | 0.270 |
Why?
|
Pandemics | 3 | 2021 | 8600 | 0.270 |
Why?
|
Facial Transplantation | 3 | 2015 | 221 | 0.260 |
Why?
|
Standard of Care | 5 | 2024 | 550 | 0.260 |
Why?
|
Consensus | 9 | 2020 | 3097 | 0.260 |
Why?
|
Abdominal Muscles | 2 | 2011 | 168 | 0.260 |
Why?
|
Models, Animal | 4 | 2017 | 2110 | 0.250 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2022 | 497 | 0.250 |
Why?
|
Wounds, Nonpenetrating | 3 | 2016 | 794 | 0.250 |
Why?
|
Learning Curve | 4 | 2016 | 229 | 0.250 |
Why?
|
Blood Preservation | 2 | 2007 | 168 | 0.250 |
Why?
|
Esthetics | 4 | 2018 | 326 | 0.250 |
Why?
|
Cohort Studies | 9 | 2023 | 41190 | 0.250 |
Why?
|
Foot | 3 | 2022 | 573 | 0.250 |
Why?
|
Keratins | 2 | 2024 | 497 | 0.250 |
Why?
|
Thermography | 1 | 2005 | 62 | 0.240 |
Why?
|
Rats, Inbred Lew | 2 | 2017 | 1154 | 0.240 |
Why?
|
Vascular Patency | 1 | 2008 | 895 | 0.240 |
Why?
|
Groin | 2 | 2008 | 106 | 0.240 |
Why?
|
Regional Blood Flow | 4 | 2013 | 1485 | 0.240 |
Why?
|
Quality of Life | 10 | 2024 | 13263 | 0.240 |
Why?
|
Amnion | 3 | 2022 | 197 | 0.230 |
Why?
|
Lymph Nodes | 2 | 2019 | 3470 | 0.230 |
Why?
|
Diffusion of Innovation | 2 | 2016 | 727 | 0.230 |
Why?
|
Swine | 12 | 2022 | 5891 | 0.230 |
Why?
|
Decompression, Surgical | 1 | 2009 | 604 | 0.230 |
Why?
|
Wound Infection | 2 | 2005 | 243 | 0.230 |
Why?
|
Therapeutic Irrigation | 2 | 2021 | 292 | 0.230 |
Why?
|
Dermatomycoses | 1 | 2004 | 48 | 0.230 |
Why?
|
Basement Membrane | 1 | 2005 | 348 | 0.230 |
Why?
|
Tissue Adhesions | 3 | 2016 | 218 | 0.230 |
Why?
|
Bone Marrow Cells | 2 | 2014 | 2411 | 0.230 |
Why?
|
Aged | 46 | 2024 | 167890 | 0.230 |
Why?
|
Cell Hypoxia | 3 | 2019 | 656 | 0.220 |
Why?
|
Scalp Dermatoses | 1 | 2004 | 44 | 0.220 |
Why?
|
Amiodarone | 1 | 2005 | 216 | 0.220 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2524 | 0.220 |
Why?
|
Specialties, Surgical | 4 | 2018 | 387 | 0.220 |
Why?
|
Matrix Metalloproteinases | 1 | 2006 | 392 | 0.220 |
Why?
|
Length of Stay | 5 | 2022 | 6384 | 0.220 |
Why?
|
Hypoalbuminemia | 1 | 2024 | 86 | 0.220 |
Why?
|
Bell Palsy | 1 | 2023 | 39 | 0.220 |
Why?
|
Education, Medical, Continuing | 2 | 2013 | 824 | 0.210 |
Why?
|
Rats | 7 | 2019 | 23676 | 0.210 |
Why?
|
Skull Fractures | 2 | 2022 | 202 | 0.210 |
Why?
|
Thoracotomy | 1 | 2004 | 363 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3077 | 0.210 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 61 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3197 | 0.210 |
Why?
|
Culture Media | 2 | 2001 | 899 | 0.210 |
Why?
|
Chorion | 2 | 2022 | 114 | 0.200 |
Why?
|
Nomograms | 1 | 2024 | 227 | 0.200 |
Why?
|
Efficiency | 3 | 2015 | 476 | 0.200 |
Why?
|
Thoracic Injuries | 1 | 2005 | 280 | 0.200 |
Why?
|
Lung Diseases, Fungal | 1 | 2003 | 126 | 0.200 |
Why?
|
Ultraviolet Rays | 1 | 2007 | 1077 | 0.200 |
Why?
|
Prospective Studies | 21 | 2024 | 54092 | 0.200 |
Why?
|
Mice, Hairless | 3 | 2017 | 39 | 0.200 |
Why?
|
Mycosis Fungoides | 1 | 2023 | 170 | 0.200 |
Why?
|
Vascular Diseases | 2 | 2008 | 1160 | 0.200 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 367 | 0.200 |
Why?
|
Body Temperature | 1 | 2005 | 777 | 0.200 |
Why?
|
Chronic Disease | 6 | 2021 | 9263 | 0.190 |
Why?
|
Periodicals as Topic | 3 | 2017 | 1460 | 0.190 |
Why?
|
Patient Care Team | 5 | 2016 | 2505 | 0.190 |
Why?
|
Bone Wires | 1 | 2021 | 124 | 0.190 |
Why?
|
Body Surface Area | 1 | 2002 | 197 | 0.190 |
Why?
|
Prostatic Diseases | 1 | 2001 | 57 | 0.190 |
Why?
|
Finite Element Analysis | 3 | 2010 | 428 | 0.190 |
Why?
|
Venous Thrombosis | 2 | 2008 | 1292 | 0.190 |
Why?
|
Nanofibers | 2 | 2011 | 65 | 0.190 |
Why?
|
Aged, 80 and over | 20 | 2024 | 58558 | 0.190 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2023 | 12078 | 0.190 |
Why?
|
Mice, Inbred NOD | 4 | 2019 | 1824 | 0.190 |
Why?
|
Aspergillosis | 1 | 2003 | 243 | 0.190 |
Why?
|
Ki-67 Antigen | 3 | 2011 | 630 | 0.180 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2005 | 776 | 0.180 |
Why?
|
Rectal Fistula | 1 | 2001 | 75 | 0.180 |
Why?
|
Epithelium | 4 | 2011 | 1605 | 0.180 |
Why?
|
Arterial Occlusive Diseases | 1 | 2005 | 747 | 0.180 |
Why?
|
Leg Injuries | 2 | 2022 | 178 | 0.180 |
Why?
|
Hypopigmentation | 1 | 2001 | 43 | 0.180 |
Why?
|
Heparin | 1 | 2008 | 1632 | 0.180 |
Why?
|
Gelatin | 2 | 2019 | 221 | 0.180 |
Why?
|
Microscopy, Confocal | 2 | 2017 | 1966 | 0.180 |
Why?
|
Oxandrolone | 1 | 2000 | 24 | 0.180 |
Why?
|
Cells, Cultured | 8 | 2019 | 18936 | 0.170 |
Why?
|
Flow Cytometry | 5 | 2017 | 5861 | 0.170 |
Why?
|
Middle East | 1 | 2020 | 230 | 0.170 |
Why?
|
Delayed-Action Preparations | 1 | 2024 | 961 | 0.170 |
Why?
|
Aftercare | 3 | 2024 | 909 | 0.170 |
Why?
|
Biomedical Research | 1 | 2015 | 3415 | 0.170 |
Why?
|
Computer Graphics | 1 | 2002 | 340 | 0.170 |
Why?
|
Plasma | 3 | 2008 | 585 | 0.170 |
Why?
|
Parabiosis | 2 | 2010 | 64 | 0.170 |
Why?
|
Cell Extracts | 1 | 2020 | 135 | 0.170 |
Why?
|
Administration, Topical | 4 | 2019 | 696 | 0.170 |
Why?
|
Fistula | 1 | 2001 | 212 | 0.170 |
Why?
|
Membrane Lipids | 1 | 2021 | 251 | 0.170 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2021 | 190 | 0.170 |
Why?
|
Rhinoplasty | 1 | 2023 | 238 | 0.170 |
Why?
|
Combined Modality Therapy | 3 | 2021 | 8512 | 0.170 |
Why?
|
Glutaral | 3 | 2007 | 76 | 0.170 |
Why?
|
Fracture Fixation, Internal | 1 | 2006 | 963 | 0.160 |
Why?
|
Cell Membrane | 3 | 2021 | 3680 | 0.160 |
Why?
|
Guided Tissue Regeneration | 1 | 2019 | 87 | 0.160 |
Why?
|
Incidental Findings | 1 | 2004 | 693 | 0.160 |
Why?
|
Materials Testing | 2 | 2017 | 860 | 0.160 |
Why?
|
Cell Differentiation | 5 | 2019 | 11469 | 0.160 |
Why?
|
Kinetics | 4 | 2013 | 6371 | 0.160 |
Why?
|
Ischemic Postconditioning | 1 | 2019 | 24 | 0.160 |
Why?
|
Vascular Surgical Procedures | 2 | 2023 | 1472 | 0.160 |
Why?
|
Reoperation | 7 | 2023 | 4279 | 0.160 |
Why?
|
Melanins | 1 | 2001 | 289 | 0.160 |
Why?
|
Bone Plates | 1 | 2021 | 465 | 0.160 |
Why?
|
Sarcopenia | 1 | 2023 | 372 | 0.160 |
Why?
|
Anti-Bacterial Agents | 4 | 2021 | 7399 | 0.160 |
Why?
|
5-Methylcytosine | 1 | 2019 | 146 | 0.160 |
Why?
|
Mastectomy, Subcutaneous | 1 | 2018 | 56 | 0.160 |
Why?
|
Risk Assessment | 11 | 2024 | 23816 | 0.160 |
Why?
|
Education, Distance | 1 | 2002 | 259 | 0.150 |
Why?
|
Ischemic Preconditioning | 1 | 2018 | 89 | 0.150 |
Why?
|
Quadriceps Muscle | 1 | 2019 | 154 | 0.150 |
Why?
|
Nipples | 2 | 2018 | 221 | 0.150 |
Why?
|
Analysis of Variance | 3 | 2016 | 6230 | 0.150 |
Why?
|
Time Factors | 12 | 2020 | 39811 | 0.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2018 | 5648 | 0.150 |
Why?
|
Patient Positioning | 1 | 2020 | 326 | 0.150 |
Why?
|
Anticoagulants | 2 | 2016 | 4777 | 0.150 |
Why?
|
Caveolin 1 | 1 | 2019 | 256 | 0.150 |
Why?
|
Anabolic Agents | 1 | 2000 | 252 | 0.140 |
Why?
|
Edema | 2 | 2013 | 769 | 0.140 |
Why?
|
Melanocytes | 1 | 2001 | 509 | 0.140 |
Why?
|
Biomimetic Materials | 1 | 2019 | 172 | 0.140 |
Why?
|
Guinea Pigs | 7 | 2004 | 1317 | 0.140 |
Why?
|
Sensitivity and Specificity | 4 | 2016 | 14637 | 0.140 |
Why?
|
Dioxygenases | 1 | 2019 | 332 | 0.140 |
Why?
|
Graft Rejection | 4 | 2018 | 4427 | 0.140 |
Why?
|
Critical Care | 1 | 2009 | 2690 | 0.130 |
Why?
|
Cross-Linking Reagents | 3 | 2007 | 686 | 0.130 |
Why?
|
Blotting, Western | 2 | 2016 | 5031 | 0.130 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2016 | 86 | 0.130 |
Why?
|
Bone Substitutes | 1 | 1998 | 236 | 0.130 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2019 | 703 | 0.130 |
Why?
|
Arthroplasty, Replacement, Knee | 3 | 2016 | 1369 | 0.130 |
Why?
|
Smad1 Protein | 1 | 2016 | 81 | 0.130 |
Why?
|
Otorhinolaryngologic Neoplasms | 1 | 2015 | 26 | 0.130 |
Why?
|
Adipose Tissue, Brown | 1 | 2021 | 755 | 0.130 |
Why?
|
Urinary Bladder | 1 | 2022 | 1148 | 0.130 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 684 | 0.130 |
Why?
|
Inflammation | 8 | 2022 | 10709 | 0.130 |
Why?
|
Forecasting | 2 | 2016 | 2919 | 0.130 |
Why?
|
Protein Kinase C-delta | 1 | 2016 | 114 | 0.130 |
Why?
|
Ascorbic Acid | 1 | 2019 | 655 | 0.130 |
Why?
|
Arrhythmias, Cardiac | 1 | 2005 | 2248 | 0.130 |
Why?
|
Hemostatics | 1 | 1998 | 240 | 0.120 |
Why?
|
Risk Factors | 13 | 2024 | 73708 | 0.120 |
Why?
|
Porosity | 3 | 2017 | 348 | 0.120 |
Why?
|
Insulin Resistance | 2 | 2021 | 3941 | 0.120 |
Why?
|
Databases, Factual | 6 | 2023 | 7927 | 0.120 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2021 | 2531 | 0.120 |
Why?
|
Medical Informatics | 1 | 2002 | 732 | 0.120 |
Why?
|
T-Lymphocytes | 3 | 2021 | 10167 | 0.120 |
Why?
|
Models, Statistical | 1 | 2009 | 5068 | 0.120 |
Why?
|
Hemangiosarcoma | 1 | 2017 | 216 | 0.120 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 2 | 2017 | 935 | 0.120 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2016 | 939 | 0.120 |
Why?
|
Electrosurgery | 1 | 2014 | 50 | 0.120 |
Why?
|
Neck | 1 | 1999 | 731 | 0.120 |
Why?
|
Mastectomy, Segmental | 2 | 2017 | 972 | 0.120 |
Why?
|
Facial Muscles | 1 | 1995 | 159 | 0.110 |
Why?
|
History, 21st Century | 2 | 2021 | 1568 | 0.110 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2016 | 553 | 0.110 |
Why?
|
Fractures, Bone | 1 | 2006 | 2039 | 0.110 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2742 | 0.110 |
Why?
|
Breast | 2 | 2018 | 1961 | 0.110 |
Why?
|
Cysteine Endopeptidases | 1 | 1996 | 548 | 0.110 |
Why?
|
Young Adult | 11 | 2024 | 58755 | 0.110 |
Why?
|
Cell Division | 4 | 2008 | 4459 | 0.110 |
Why?
|
Elbow | 1 | 1994 | 130 | 0.110 |
Why?
|
Myometrium | 1 | 2014 | 174 | 0.110 |
Why?
|
Gels | 1 | 2014 | 419 | 0.110 |
Why?
|
Hyaluronic Acid | 1 | 2017 | 482 | 0.110 |
Why?
|
Atmospheric Pressure | 2 | 2006 | 46 | 0.110 |
Why?
|
Necrosis | 4 | 2022 | 1604 | 0.110 |
Why?
|
Explosions | 1 | 2013 | 108 | 0.110 |
Why?
|
Inpatients | 3 | 2022 | 2536 | 0.110 |
Why?
|
Oligonucleotides, Antisense | 1 | 2016 | 459 | 0.110 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2017 | 547 | 0.110 |
Why?
|
Lasers, Gas | 1 | 2014 | 94 | 0.110 |
Why?
|
Chondrogenesis | 1 | 2014 | 239 | 0.110 |
Why?
|
Biophysical Phenomena | 1 | 2013 | 320 | 0.110 |
Why?
|
Catheterization | 2 | 2011 | 1426 | 0.110 |
Why?
|
Face | 1 | 1999 | 1017 | 0.100 |
Why?
|
Polymers | 1 | 2020 | 1612 | 0.100 |
Why?
|
MAP Kinase Signaling System | 1 | 2020 | 1477 | 0.100 |
Why?
|
Ear, External | 2 | 2007 | 164 | 0.100 |
Why?
|
Injury Severity Score | 2 | 2020 | 1032 | 0.100 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2014 | 320 | 0.100 |
Why?
|
Embryonic Stem Cells | 1 | 2020 | 1262 | 0.100 |
Why?
|
Mice, SCID | 1 | 2017 | 2625 | 0.100 |
Why?
|
Coronary Artery Bypass | 3 | 2015 | 2188 | 0.100 |
Why?
|
Surgery Department, Hospital | 1 | 2013 | 176 | 0.100 |
Why?
|
Blood Transfusion | 1 | 2019 | 1295 | 0.100 |
Why?
|
History, 20th Century | 2 | 2021 | 2769 | 0.100 |
Why?
|
Polyethylene Glycols | 1 | 1998 | 1188 | 0.100 |
Why?
|
Rabbits | 3 | 2005 | 4772 | 0.100 |
Why?
|
Cell Culture Techniques | 3 | 2009 | 1664 | 0.100 |
Why?
|
Biophysics | 1 | 2013 | 380 | 0.100 |
Why?
|
Pelvis | 1 | 2016 | 732 | 0.100 |
Why?
|
Fibrosis | 4 | 2023 | 2038 | 0.100 |
Why?
|
Pneumonectomy | 3 | 2023 | 1110 | 0.100 |
Why?
|
Preoperative Care | 1 | 2021 | 2246 | 0.100 |
Why?
|
Follow-Up Studies | 13 | 2019 | 39020 | 0.100 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2011 | 59 | 0.100 |
Why?
|
United States | 11 | 2024 | 71902 | 0.100 |
Why?
|
Checklist | 3 | 2019 | 827 | 0.100 |
Why?
|
Lymphangiogenesis | 2 | 2023 | 172 | 0.100 |
Why?
|
Cooperative Behavior | 2 | 2016 | 1502 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1795 | 0.090 |
Why?
|
Diaphragm | 1 | 2013 | 351 | 0.090 |
Why?
|
Air Pressure | 1 | 2011 | 74 | 0.090 |
Why?
|
Gene Expression Regulation | 6 | 2016 | 11890 | 0.090 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5798 | 0.090 |
Why?
|
Quality Assurance, Health Care | 2 | 2013 | 2167 | 0.090 |
Why?
|
Protein Denaturation | 3 | 2005 | 242 | 0.090 |
Why?
|
Terrorism | 1 | 2013 | 211 | 0.090 |
Why?
|
Cell Degranulation | 1 | 2011 | 276 | 0.090 |
Why?
|
Myofibroblasts | 1 | 2012 | 207 | 0.090 |
Why?
|
Signal Transduction | 5 | 2021 | 23335 | 0.090 |
Why?
|
Serum Albumin | 2 | 2024 | 672 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2443 | 0.090 |
Why?
|
Abdomen | 1 | 2016 | 1126 | 0.090 |
Why?
|
Oxygen | 2 | 2013 | 4190 | 0.090 |
Why?
|
Statistics, Nonparametric | 2 | 2017 | 2847 | 0.090 |
Why?
|
Bone Regeneration | 1 | 2013 | 432 | 0.090 |
Why?
|
Androgen Antagonists | 1 | 2019 | 1400 | 0.090 |
Why?
|
Linear Models | 2 | 2013 | 5856 | 0.090 |
Why?
|
Blast Injuries | 1 | 2013 | 322 | 0.090 |
Why?
|
Migraine Disorders | 1 | 2022 | 1694 | 0.090 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 3069 | 0.090 |
Why?
|
Prognosis | 6 | 2019 | 29488 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2019 | 1584 | 0.090 |
Why?
|
Internet | 1 | 2002 | 3081 | 0.090 |
Why?
|
Irritants | 1 | 2009 | 43 | 0.080 |
Why?
|
Hyperemia | 1 | 2011 | 221 | 0.080 |
Why?
|
Biofilms | 1 | 2014 | 621 | 0.080 |
Why?
|
Physical Therapy Modalities | 1 | 2013 | 536 | 0.080 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2010 | 225 | 0.080 |
Why?
|
Dioxoles | 1 | 2009 | 95 | 0.080 |
Why?
|
Tetrahydroisoquinolines | 1 | 2009 | 81 | 0.080 |
Why?
|
K562 Cells | 2 | 2021 | 639 | 0.080 |
Why?
|
Oxidative Stress | 1 | 2020 | 3102 | 0.080 |
Why?
|
Immunosuppressive Agents | 2 | 2019 | 4159 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2619 | 0.080 |
Why?
|
Muscle, Skeletal | 2 | 2004 | 4901 | 0.080 |
Why?
|
Massachusetts | 2 | 2018 | 8815 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2019 | 3206 | 0.080 |
Why?
|
Cell Movement | 4 | 2019 | 5196 | 0.080 |
Why?
|
Hysterectomy | 1 | 2014 | 852 | 0.080 |
Why?
|
Skin Diseases | 1 | 2017 | 1088 | 0.080 |
Why?
|
Fasciitis, Necrotizing | 1 | 2009 | 79 | 0.080 |
Why?
|
Multicenter Studies as Topic | 2 | 2024 | 1703 | 0.080 |
Why?
|
Mice, Nude | 3 | 2019 | 3600 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2022 | 1788 | 0.080 |
Why?
|
Medical Staff, Hospital | 1 | 2012 | 600 | 0.080 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2022 | 458 | 0.080 |
Why?
|
Soft Tissue Neoplasms | 2 | 2012 | 1152 | 0.080 |
Why?
|
Upper Extremity | 2 | 2012 | 661 | 0.080 |
Why?
|
Physician Incentive Plans | 1 | 2009 | 164 | 0.070 |
Why?
|
Otolaryngology | 1 | 2015 | 685 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2011 | 3664 | 0.070 |
Why?
|
Disaster Planning | 1 | 2013 | 557 | 0.070 |
Why?
|
Dimethyl Sulfoxide | 1 | 2008 | 251 | 0.070 |
Why?
|
Cryoprotective Agents | 1 | 2008 | 128 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2017 | 9245 | 0.070 |
Why?
|
Incidence | 4 | 2023 | 21217 | 0.070 |
Why?
|
Teaching | 1 | 2015 | 1168 | 0.070 |
Why?
|
Cell Count | 2 | 2014 | 1834 | 0.070 |
Why?
|
Pilot Projects | 4 | 2022 | 8550 | 0.070 |
Why?
|
Laser Therapy | 1 | 2014 | 1082 | 0.070 |
Why?
|
Orthopedics | 1 | 2016 | 892 | 0.070 |
Why?
|
Hospitals, Military | 1 | 2007 | 62 | 0.070 |
Why?
|
Ear | 1 | 2007 | 172 | 0.070 |
Why?
|
Rats, Wistar | 2 | 2007 | 1841 | 0.070 |
Why?
|
Quality Control | 2 | 2020 | 825 | 0.070 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2009 | 691 | 0.070 |
Why?
|
Radiography | 2 | 2016 | 6956 | 0.070 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 886 | 0.070 |
Why?
|
Photomicrography | 1 | 2006 | 71 | 0.070 |
Why?
|
Sciatic Neuropathy | 1 | 2007 | 75 | 0.070 |
Why?
|
Acute Disease | 3 | 2021 | 7225 | 0.070 |
Why?
|
Ticlopidine | 1 | 2011 | 730 | 0.070 |
Why?
|
Organizations, Nonprofit | 1 | 2007 | 104 | 0.070 |
Why?
|
Patient Selection | 1 | 2018 | 4235 | 0.070 |
Why?
|
Microvessels | 1 | 2011 | 572 | 0.070 |
Why?
|
Vietnam | 1 | 2007 | 409 | 0.070 |
Why?
|
Fasciitis | 1 | 2007 | 67 | 0.070 |
Why?
|
Sarcoma | 2 | 2012 | 1784 | 0.060 |
Why?
|
DNA Primers | 1 | 2010 | 2816 | 0.060 |
Why?
|
Macrophages | 2 | 2018 | 5732 | 0.060 |
Why?
|
Receptors, CXCR4 | 1 | 2010 | 727 | 0.060 |
Why?
|
Leiomyosarcoma | 1 | 2009 | 423 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2016 | 22022 | 0.060 |
Why?
|
Peripheral Vascular Diseases | 1 | 2008 | 488 | 0.060 |
Why?
|
Burn Units | 1 | 2006 | 141 | 0.060 |
Why?
|
Microfluidics | 1 | 2010 | 652 | 0.060 |
Why?
|
North America | 2 | 2019 | 1273 | 0.060 |
Why?
|
Chemical Phenomena | 2 | 2012 | 508 | 0.060 |
Why?
|
Biopsy | 3 | 2017 | 6757 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2006 | 255 | 0.060 |
Why?
|
Sulfonamides | 1 | 2014 | 1972 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2002 | 8946 | 0.060 |
Why?
|
Urban Health Services | 1 | 2006 | 176 | 0.060 |
Why?
|
Protein Folding | 2 | 2005 | 866 | 0.060 |
Why?
|
Glycoproteins | 1 | 2012 | 2205 | 0.060 |
Why?
|
Patient Discharge | 3 | 2024 | 3428 | 0.060 |
Why?
|
Surgical Instruments | 1 | 2007 | 382 | 0.060 |
Why?
|
Up-Regulation | 2 | 2011 | 4110 | 0.060 |
Why?
|
Pyrazoles | 1 | 2014 | 1992 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3502 | 0.060 |
Why?
|
Depression | 1 | 2024 | 8049 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4737 | 0.060 |
Why?
|
Adolescent | 11 | 2016 | 87819 | 0.060 |
Why?
|
Cellulitis | 1 | 2006 | 208 | 0.060 |
Why?
|
Fellowships and Scholarships | 1 | 2012 | 1113 | 0.060 |
Why?
|
Postoperative Period | 2 | 2018 | 1806 | 0.060 |
Why?
|
Cells | 1 | 2005 | 164 | 0.060 |
Why?
|
Head and Neck Neoplasms | 2 | 2015 | 2881 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2016 | 3440 | 0.060 |
Why?
|
Liver Function Tests | 1 | 2005 | 522 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2010 | 866 | 0.060 |
Why?
|
Comprehension | 1 | 2009 | 618 | 0.060 |
Why?
|
Data Interpretation, Statistical | 2 | 2013 | 2687 | 0.050 |
Why?
|
Canada | 2 | 2019 | 2109 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2016 | 1847 | 0.050 |
Why?
|
Cryopreservation | 1 | 2008 | 717 | 0.050 |
Why?
|
Evans Blue | 1 | 2023 | 42 | 0.050 |
Why?
|
Craniocerebral Trauma | 1 | 2007 | 490 | 0.050 |
Why?
|
Limb Salvage | 1 | 2006 | 464 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2017 | 3524 | 0.050 |
Why?
|
Capillaries | 1 | 2006 | 744 | 0.050 |
Why?
|
Blood Vessels | 1 | 2008 | 1112 | 0.050 |
Why?
|
Collateral Circulation | 1 | 2004 | 292 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2022 | 12761 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2005 | 1433 | 0.050 |
Why?
|
Reference Values | 2 | 2019 | 4918 | 0.050 |
Why?
|
Cell Line | 3 | 2021 | 15587 | 0.050 |
Why?
|
Angiography | 1 | 2008 | 1598 | 0.050 |
Why?
|
Cell Adhesion Molecules | 1 | 2008 | 1600 | 0.050 |
Why?
|
Cell Survival | 3 | 2017 | 5781 | 0.050 |
Why?
|
Ischemia | 2 | 2022 | 1863 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2017 | 12047 | 0.050 |
Why?
|
Contracture | 2 | 2007 | 235 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2018 | 6807 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4257 | 0.050 |
Why?
|
Computer Simulation | 3 | 2005 | 6198 | 0.050 |
Why?
|
Granulocyte Colony-Stimulating Factor | 2 | 2010 | 629 | 0.050 |
Why?
|
Algorithms | 3 | 2014 | 13952 | 0.050 |
Why?
|
Chondroitin Sulfates | 1 | 2001 | 174 | 0.050 |
Why?
|
Suture Techniques | 2 | 2010 | 771 | 0.050 |
Why?
|
Integrins | 2 | 2013 | 834 | 0.050 |
Why?
|
Educational Measurement | 1 | 2008 | 1245 | 0.050 |
Why?
|
Instillation, Drug | 1 | 2021 | 32 | 0.050 |
Why?
|
Patient Readmission | 1 | 2015 | 3241 | 0.050 |
Why?
|
Glass | 1 | 2021 | 115 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2016 | 3432 | 0.050 |
Why?
|
Ulcer | 1 | 2022 | 204 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 7982 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 25924 | 0.050 |
Why?
|
PPAR gamma | 1 | 2023 | 481 | 0.050 |
Why?
|
Bacterial Infections | 1 | 2009 | 1402 | 0.050 |
Why?
|
Sus scrofa | 2 | 2014 | 428 | 0.050 |
Why?
|
Program Development | 1 | 2007 | 1296 | 0.050 |
Why?
|
Proteins | 2 | 2005 | 6024 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2022 | 5194 | 0.040 |
Why?
|
International Cooperation | 1 | 2007 | 1428 | 0.040 |
Why?
|
Quality Indicators, Health Care | 3 | 2016 | 1791 | 0.040 |
Why?
|
Internship and Residency | 2 | 2012 | 5854 | 0.040 |
Why?
|
Phototherapy | 1 | 2023 | 368 | 0.040 |
Why?
|
RNA | 1 | 2010 | 2716 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2012 | 2354 | 0.040 |
Why?
|
Body Mass Index | 1 | 2018 | 12868 | 0.040 |
Why?
|
Age Factors | 3 | 2018 | 18326 | 0.040 |
Why?
|
Data Collection | 1 | 2009 | 3319 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13268 | 0.040 |
Why?
|
Electric Injuries | 1 | 1999 | 24 | 0.040 |
Why?
|
Learning | 1 | 2009 | 1738 | 0.040 |
Why?
|
Biology | 1 | 2022 | 289 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3799 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 2 | 2004 | 4046 | 0.040 |
Why?
|
Thermodynamics | 3 | 2005 | 595 | 0.040 |
Why?
|
Neoplasms | 1 | 2008 | 21986 | 0.040 |
Why?
|
Survival Analysis | 2 | 2017 | 10075 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2002 | 1628 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2020 | 9514 | 0.040 |
Why?
|
Hodgkin Disease | 1 | 2007 | 1377 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2006 | 1651 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2016 | 2469 | 0.040 |
Why?
|
Mice, Knockout | 1 | 2014 | 14345 | 0.040 |
Why?
|
Base Sequence | 1 | 2010 | 12437 | 0.040 |
Why?
|
Prosthesis-Related Infections | 2 | 2008 | 486 | 0.040 |
Why?
|
Methacrylates | 1 | 2019 | 109 | 0.040 |
Why?
|
Bacteremia | 1 | 2006 | 978 | 0.040 |
Why?
|
Integrin alpha6beta4 | 1 | 1998 | 30 | 0.040 |
Why?
|
Administration, Cutaneous | 1 | 2001 | 711 | 0.040 |
Why?
|
Gene Expression | 2 | 2023 | 7584 | 0.040 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2019 | 186 | 0.040 |
Why?
|
Program Evaluation | 1 | 2007 | 2491 | 0.040 |
Why?
|
Anti-Infective Agents, Local | 1 | 2021 | 247 | 0.040 |
Why?
|
3T3 Cells | 1 | 2020 | 1084 | 0.040 |
Why?
|
Tissue Transplantation | 1 | 2019 | 128 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2014 | 9403 | 0.040 |
Why?
|
Chemistry, Physical | 1 | 1998 | 154 | 0.040 |
Why?
|
Laparoscopy | 1 | 2010 | 2032 | 0.040 |
Why?
|
Injections, Intralesional | 1 | 2019 | 277 | 0.040 |
Why?
|
Protein Conformation | 1 | 2005 | 3966 | 0.040 |
Why?
|
Mice, Obese | 1 | 2018 | 420 | 0.040 |
Why?
|
Culture Techniques | 1 | 1998 | 530 | 0.040 |
Why?
|
Ultrasonography | 2 | 2015 | 5951 | 0.040 |
Why?
|
Transillumination | 1 | 2017 | 20 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 553 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15781 | 0.040 |
Why?
|
Tissue Adhesives | 1 | 2019 | 173 | 0.040 |
Why?
|
Organ Culture Techniques | 1 | 2020 | 794 | 0.040 |
Why?
|
Neck Injuries | 1 | 1999 | 160 | 0.040 |
Why?
|
Viscosity | 1 | 1998 | 335 | 0.040 |
Why?
|
Phospholipids | 1 | 2021 | 784 | 0.040 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2018 | 168 | 0.040 |
Why?
|
Blood Glucose | 2 | 2022 | 6349 | 0.040 |
Why?
|
Carotid Artery Injuries | 1 | 1997 | 96 | 0.030 |
Why?
|
Health Services | 1 | 2002 | 752 | 0.030 |
Why?
|
Laminin | 1 | 1998 | 405 | 0.030 |
Why?
|
Empyema, Pleural | 1 | 1997 | 61 | 0.030 |
Why?
|
Penis | 1 | 1997 | 212 | 0.030 |
Why?
|
Liver Diseases | 1 | 2005 | 1296 | 0.030 |
Why?
|
Immunomodulation | 1 | 2020 | 544 | 0.030 |
Why?
|
Cattle | 2 | 2001 | 3846 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2023 | 2696 | 0.030 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2016 | 47 | 0.030 |
Why?
|
Models, Biological | 4 | 2007 | 9459 | 0.030 |
Why?
|
Replantation | 1 | 1997 | 145 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2004 | 3591 | 0.030 |
Why?
|
Factor VIII | 1 | 1998 | 348 | 0.030 |
Why?
|
Amputation, Traumatic | 1 | 1997 | 135 | 0.030 |
Why?
|
Journal Impact Factor | 1 | 2017 | 153 | 0.030 |
Why?
|
Hypopharyngeal Neoplasms | 1 | 2015 | 51 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2024 | 20037 | 0.030 |
Why?
|
Placebos | 1 | 2000 | 1661 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2021 | 1254 | 0.030 |
Why?
|
Tropical Climate | 1 | 1995 | 34 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2022 | 5243 | 0.030 |
Why?
|
Muscle Strength | 1 | 2019 | 618 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 611 | 0.030 |
Why?
|
Lymphangioma, Cystic | 1 | 1995 | 34 | 0.030 |
Why?
|
Fracture Healing | 1 | 1998 | 437 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2016 | 319 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2003 | 1598 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2263 | 0.030 |
Why?
|
Complementary Therapies | 1 | 2019 | 486 | 0.030 |
Why?
|
Half-Life | 1 | 2016 | 652 | 0.030 |
Why?
|
Bone Development | 1 | 1998 | 472 | 0.030 |
Why?
|
Hyperplasia | 1 | 1998 | 1153 | 0.030 |
Why?
|
Facial Bones | 1 | 1996 | 205 | 0.030 |
Why?
|
Child, Preschool | 6 | 2023 | 42045 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2248 | 0.030 |
Why?
|
Comorbidity | 1 | 2009 | 10477 | 0.030 |
Why?
|
Stevens-Johnson Syndrome | 1 | 1997 | 243 | 0.030 |
Why?
|
Health Surveys | 1 | 2024 | 4056 | 0.030 |
Why?
|
Protein Precursors | 1 | 1998 | 1133 | 0.030 |
Why?
|
Antigens, Surface | 1 | 1998 | 1607 | 0.030 |
Why?
|
Ultrasonics | 1 | 2015 | 206 | 0.030 |
Why?
|
Pneumonia | 2 | 2016 | 2127 | 0.030 |
Why?
|
Mammography | 1 | 2004 | 2424 | 0.030 |
Why?
|
Bursitis | 1 | 1994 | 80 | 0.030 |
Why?
|
Language | 1 | 2022 | 1529 | 0.030 |
Why?
|
Carotid Arteries | 1 | 1997 | 939 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1647 | 0.030 |
Why?
|
Fibrosarcoma | 1 | 1995 | 308 | 0.030 |
Why?
|
Shoulder | 1 | 1995 | 299 | 0.030 |
Why?
|
Constriction | 1 | 2012 | 171 | 0.030 |
Why?
|
Cysts | 1 | 1998 | 681 | 0.030 |
Why?
|
Transient Receptor Potential Channels | 1 | 2013 | 130 | 0.030 |
Why?
|
Human Growth Hormone | 1 | 1997 | 638 | 0.030 |
Why?
|
Energy Intake | 1 | 2000 | 2128 | 0.030 |
Why?
|
Extremities | 1 | 1997 | 865 | 0.020 |
Why?
|
Axilla | 1 | 1995 | 626 | 0.020 |
Why?
|
Myositis | 1 | 1995 | 269 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 1997 | 815 | 0.020 |
Why?
|
Gap Junctions | 1 | 2013 | 230 | 0.020 |
Why?
|
Laryngeal Neoplasms | 1 | 2015 | 514 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2013 | 500 | 0.020 |
Why?
|
Thorax | 1 | 1995 | 553 | 0.020 |
Why?
|
Metaplasia | 1 | 2012 | 321 | 0.020 |
Why?
|
Liver | 2 | 2014 | 7502 | 0.020 |
Why?
|
Psychometrics | 1 | 2021 | 3051 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1609 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12397 | 0.020 |
Why?
|
Facial Expression | 1 | 1995 | 508 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 1997 | 1094 | 0.020 |
Why?
|
Palliative Care | 1 | 2006 | 3568 | 0.020 |
Why?
|
Physicians | 1 | 2009 | 4577 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 3994 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2048 | 0.020 |
Why?
|
Fruit | 1 | 1996 | 1158 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2011 | 751 | 0.020 |
Why?
|
Duodenoscopy | 1 | 2010 | 45 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2015 | 11082 | 0.020 |
Why?
|
Rosacea | 1 | 2011 | 59 | 0.020 |
Why?
|
Boston | 2 | 2013 | 9298 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2021 | 5489 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2019 | 6204 | 0.020 |
Why?
|
Cadaver | 1 | 1994 | 1345 | 0.020 |
Why?
|
Muscle Contraction | 1 | 1995 | 1196 | 0.020 |
Why?
|
Proteome | 1 | 2020 | 1852 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4550 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2014 | 759 | 0.020 |
Why?
|
Muscles | 1 | 1994 | 1575 | 0.020 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2015 | 491 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2014 | 1336 | 0.020 |
Why?
|
Breast Implantation | 1 | 2012 | 222 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 2016 | 806 | 0.020 |
Why?
|
Benchmarking | 1 | 2016 | 1041 | 0.020 |
Why?
|
Risk Adjustment | 1 | 2013 | 599 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2969 | 0.020 |
Why?
|
Cell Transdifferentiation | 1 | 2010 | 185 | 0.020 |
Why?
|
Child | 6 | 2016 | 79782 | 0.020 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2009 | 101 | 0.020 |
Why?
|
Causality | 1 | 2015 | 1239 | 0.020 |
Why?
|
Anxiety | 1 | 2024 | 4532 | 0.020 |
Why?
|
Cilia | 1 | 2013 | 493 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2800 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6292 | 0.020 |
Why?
|
Gastroscopy | 1 | 2010 | 210 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1997 | 2198 | 0.020 |
Why?
|
Cervicoplasty | 1 | 2007 | 8 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8296 | 0.020 |
Why?
|
Heart-Assist Devices | 1 | 1998 | 1279 | 0.020 |
Why?
|
Licensure, Medical | 1 | 2008 | 68 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2020 | 3043 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2019 | 8143 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2211 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2014 | 1475 | 0.020 |
Why?
|
Prevalence | 1 | 2024 | 15640 | 0.020 |
Why?
|
Bone and Bones | 1 | 1998 | 2558 | 0.020 |
Why?
|
Cardiopulmonary Bypass | 1 | 2012 | 1093 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5063 | 0.020 |
Why?
|
Health Personnel | 1 | 2021 | 3309 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2002 | 4307 | 0.020 |
Why?
|
Erythrocyte Transfusion | 1 | 2011 | 562 | 0.020 |
Why?
|
Transgenes | 1 | 2010 | 1007 | 0.020 |
Why?
|
Nutritional Physiological Phenomena | 1 | 1988 | 362 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6337 | 0.020 |
Why?
|
Fetus | 1 | 2014 | 1860 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3809 | 0.020 |
Why?
|
Growth Hormone | 1 | 1988 | 568 | 0.020 |
Why?
|
Growth Substances | 1 | 1988 | 768 | 0.020 |
Why?
|
Models, Theoretical | 1 | 1998 | 3560 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 1995 | 1406 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2000 | 12261 | 0.020 |
Why?
|
Models, Educational | 1 | 2008 | 373 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2009 | 617 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3752 | 0.020 |
Why?
|
Accreditation | 1 | 2008 | 472 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36270 | 0.020 |
Why?
|
Microscopy | 1 | 2010 | 884 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4372 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2212 | 0.010 |
Why?
|
Solutions | 1 | 2005 | 411 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2056 | 0.010 |
Why?
|
Catheterization, Central Venous | 1 | 2009 | 527 | 0.010 |
Why?
|
Device Removal | 1 | 2009 | 629 | 0.010 |
Why?
|
Mathematics | 1 | 2005 | 707 | 0.010 |
Why?
|
Heart Arrest | 1 | 2014 | 1494 | 0.010 |
Why?
|
Myocardial Infarction | 2 | 2016 | 11422 | 0.010 |
Why?
|
Hemorrhage | 1 | 2016 | 3399 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5483 | 0.010 |
Why?
|
Glucose | 1 | 2016 | 4336 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2009 | 747 | 0.010 |
Why?
|
Drainage | 1 | 2009 | 1155 | 0.010 |
Why?
|
Genes | 1 | 2007 | 1844 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 606 | 0.010 |
Why?
|
Models, Chemical | 1 | 2005 | 610 | 0.010 |
Why?
|
Lipid Bilayers | 1 | 2005 | 383 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5325 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8503 | 0.010 |
Why?
|
Colonoscopy | 1 | 2010 | 1385 | 0.010 |
Why?
|
Leiomyoma | 1 | 2006 | 631 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2012 | 2809 | 0.010 |
Why?
|
Insulin | 1 | 2016 | 6578 | 0.010 |
Why?
|
Bronchoscopy | 1 | 2007 | 909 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15207 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 2008 | 981 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 3996 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2016 | 5638 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 2901 | 0.010 |
Why?
|
Water | 1 | 2005 | 1399 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2005 | 1342 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3774 | 0.010 |
Why?
|
Membranes, Artificial | 1 | 1981 | 365 | 0.010 |
Why?
|
Mitochondrial Proteins | 1 | 2005 | 976 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2007 | 1740 | 0.010 |
Why?
|
Deceleration | 1 | 1997 | 10 | 0.010 |
Why?
|
Uterine Neoplasms | 1 | 2006 | 1414 | 0.010 |
Why?
|
Dermabrasion | 1 | 1997 | 16 | 0.010 |
Why?
|
Seat Belts | 1 | 1997 | 60 | 0.010 |
Why?
|
Amputation Stumps | 1 | 1997 | 38 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14473 | 0.010 |
Why?
|
Tissue Survival | 1 | 1997 | 119 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 12951 | 0.010 |
Why?
|
Maxillary Fractures | 1 | 1996 | 21 | 0.010 |
Why?
|
Zygomatic Fractures | 1 | 1996 | 35 | 0.010 |
Why?
|
Microscopy, Electron | 2 | 1990 | 2558 | 0.010 |
Why?
|
Palate, Hard | 1 | 1996 | 58 | 0.010 |
Why?
|
Aortography | 1 | 1997 | 420 | 0.010 |
Why?
|
Homeostasis | 1 | 2006 | 3299 | 0.010 |
Why?
|
Models, Molecular | 1 | 2005 | 5406 | 0.010 |
Why?
|
Fractures, Comminuted | 1 | 1996 | 57 | 0.010 |
Why?
|
Suppuration | 1 | 1995 | 61 | 0.010 |
Why?
|
Mandibular Fractures | 1 | 1996 | 76 | 0.010 |
Why?
|
Orbital Fractures | 1 | 1996 | 109 | 0.010 |
Why?
|
Alveolar Process | 1 | 1996 | 294 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16533 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1996 | 20499 | 0.010 |
Why?
|
Veins | 1 | 1997 | 764 | 0.010 |
Why?
|
Parenteral Nutrition | 1 | 1997 | 656 | 0.010 |
Why?
|
Fatal Outcome | 1 | 1997 | 1828 | 0.010 |
Why?
|
Nose | 1 | 1996 | 519 | 0.010 |
Why?
|
Models, Anatomic | 1 | 1996 | 679 | 0.010 |
Why?
|
Arm | 1 | 1995 | 584 | 0.010 |
Why?
|
Bone Transplantation | 1 | 1996 | 922 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2007 | 6457 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2005 | 5786 | 0.010 |
Why?
|
Biodegradation, Environmental | 1 | 1990 | 219 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2007 | 6323 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 1994 | 939 | 0.000 |
Why?
|
Membrane Proteins | 1 | 2005 | 7840 | 0.000 |
Why?
|
Morphogenesis | 1 | 1989 | 740 | 0.000 |
Why?
|
Endoscopy | 1 | 1994 | 1832 | 0.000 |
Why?
|
Infant | 2 | 1997 | 36045 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1995 | 12951 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1997 | 26176 | 0.000 |
Why?
|